Adverse events of targeted therapies reported by patients with cancer treated in primary care

References

• European health report 2018. More than numbers – evidence for all (2018) [Internet]. 2018 [cited 2019 Nov 23]. Available from: http://www.euro.who.int/en/data-and-evidence/european-health-report/european-health-report-2018/european-health-report-2018.-more-than-numbers-evidence-for-all-2018
   Google Scholar
• Kav S , Johnson J , Rittenberg C , et al. Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an International survey. Support Care Cancer. 2008;16:1075–1083.
   PubMed Web of Science ®Google Scholar
• Johnsen AT , Eskildsen NB , Thomsen TG , et al. Conceptualizing patient empowerment in cancer follow-up by combining theory and qualitative data. Acta Oncol. 2017;56:232–238.
   PubMed Web of Science ®Google Scholar
• Basch E , Deal AM , Kris MG , et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol. 2016;34:557–565.
   PubMed Web of Science ®Google Scholar
• Nugteren IC , Duineveld LAM , Wieldraaijer T , et al. Need for general practitioner involvement and eHealth in colon cancer survivorship care: patients’ perspectives. Fam Pract. 2017;34:473–478.
   PubMed Web of Science ®Google Scholar
• Rouge Bugat ME. le medecin généraliste face aux nouvelles thérapeutiques anticancéreuses. Exercer. 2017;28:404–411.
   Google Scholar
• Rubin G , Berendsen A , Crawford SM , et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231–1272.
   PubMed Web of Science ®Google Scholar
• Regnier-Denois V , Poirson J , Pouyalet FS , et al. La chimiothérapie par voie orale: représentations et pratiques des oncologues et des patients. Psycho Oncologie. 2009;3:168–175.
   Google Scholar
• Jabaaij L , van den Akker M , Schellevis FG. Excess of health care use in general practice and of comorbid chronic conditions in cancer patients compared to controls. BMC Fam Pract. 2012;13:60.
   PubMed Web of Science ®Google Scholar
• Bellomo C. Oral chemotherapy: patient education and nursing intervention. J Oncol Navig Surviv. 2016;7:6.
   Google Scholar
• Brunot A , Le Roy F , Le Sourd S , et al. Implementation of a nurse-driven educational program improves management of sorafenib’s toxicities in hepatocellular carcinoma. Cancer Nurs. 2018;41:418–423.
   PubMed Web of Science ®Google Scholar
• Valderas JM , Alonso J. Patient reported outcome measures: a model-based classification system for research and clinical practice. Qual Life Res. 2008;9:1125–1135.
   Google Scholar
• Takeuchi EE , Keding A , Awad N , et al. Impact of patient-reported outcomes in oncology: a longitudinal analysis of patient-physician communication. J Clin Oncol. 2011;29:2910–2917.
   PubMed Web of Science ®Google Scholar
• Kotronoulas G , Kearney N , Maguire R , et al. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol. 2014;32:1480–1501.
   PubMed Web of Science ®Google Scholar
• Eton DT , Yost KJ , Cella D. Future trends in patient-reported outcomes assessment for patients with advanced-stage lung cancer receiving targeted therapy. Clin Lung Cancer. 2006;8:99–109.
   PubMed Web of Science ®Google Scholar
• Chan A , Cameron MC , Garden B , et al. A systematic review of patient-reported outcome instruments of dermatologic adverse events associated with targeted cancer therapies. Support Care Cancer. 2015;23:2231–2244.
   PubMed Web of Science ®Google Scholar
• Denis F , Basch E , Septans A-L , et al. Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. J Am Med Assoc. 2019;321:306–307.
   PubMed Web of Science ®Google Scholar
• Common Terminology Criteria for Adverse Events (CTCAE). 2017. p. 155.
   Google Scholar
• Dueck AC , Mendoza TR , Mitchell SA , et al. Validity and reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JAMA Oncol. 2015;1:1051–1059.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute . NCI PRO-CTCAE Item French. 2018.
   Google Scholar
• Finn RS , Crown JP , Ettl J , et al. Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18. Breast Cancer Res. 2016;18:67.
   PubMed Web of Science ®Google Scholar
• Turner NC , Ro J , André F , et al. Palbociclib in hormone-receptor–positive advanced breast cancer. N Engl J Med. 2015;373:209–219.
   PubMed Web of Science ®Google Scholar
• Richardson A , Ream E. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur J Cancer Care (Engl). 1996;5:24–30.
   PubMedGoogle Scholar
• Rosman S. L’expérience de la fatigue chez les malades atteints de cancer. Sante Publique (Bucur). 2004;16:509–520.
   Google Scholar
• Wulff H. The two cultures of medicine: objective facts versus subjectivity and values. J R Soc Med. 1999;92:549–552.
   PubMed Web of Science ®Google Scholar
• Di Maio M , Gallo C , Leighl NB , et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials. J Clin Oncol. 2015;33:910–915.
   PubMed Web of Science ®Google Scholar
• Fromme EK , Eilers KM , Mori M , et al. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. J Clin Oncol. 2004;22:3485–3490.
   PubMed Web of Science ®Google Scholar
• Rouge Bugat M-E , Omnes C , Delpierre C , et al. Primary care physicians and oncologists are partners in cancer announcement. Support Care Cancer. 2016;24:2473–2479.
   PubMed Web of Science ®Google Scholar
• Chevrier R , Praagh IV , Chollet P , et al. Évaluation de L’observance Des Thérapeutiques Orales en Oncologie: résultats D’une Étude Pilote. Journal de Pharmacie Clinique. 2011;30:83–93.
   Google Scholar
• Gillman L , Adams J , Kovac R , et al. Strategies to promote coping and resilience in oncology and palliative care nurses caring for adult patients with malignancy: a comprehensive systematic review. JBI Database Syst Rev Implement Rep. 2015;13:131–204.
   PubMedGoogle Scholar
• Rouge Bugat ME , Dufossé V , Paul C , et al. Communicating information to the general practitioner: the example of vemurafenib for metastatic melanoma. J Eur Acad Dermatol Venereol. 2016;30:e192–e194.
   PubMed Web of Science ®Google Scholar
• Rouge-Bugat M-E , Lassoued D , Bacrie J , et al. Guideline sheets on the side effects of anticancer drugs are useful for general practitioners. Support Care Cancer. 2015;23:3473–3480.
   PubMed Web of Science ®Google Scholar
• van Leeuwen A , Wind J , van Weert H , et al. Experiences of general practitioners participating in oncology meetings with specialists to support GP-led survivorship care; an interview study from the Netherlands. Eur J Gen Pract. 2018;24:171–176.
   PubMed Web of Science ®Google Scholar
• Pype P , Mertens F , Belche J , et al. Experiences of hospital-based multidisciplinary team meetings in oncology: An interview study among participating general practitioners. Eur J Gen Pract. 2017;23:156–164.
   Web of Science ®Google Scholar
• Grunfeld E. Cancer survivorship: a challenge for primary care physicians. Br J Gen Pract. 2005;55:741–742.
   PubMed Web of Science ®Google Scholar
• Bourmaud A , Anota A , Moncharmont C , et al. Cancer-related fatigue management: evaluation of a patient education program with a large-scale randomised controlled trial, the PEPs fatigue study. Br J Cancer. 2017;116:849–858.
   PubMed Web of Science ®Google Scholar